4CPS-154 Follow-up in the use of biotherapies in crohn’s disease in a french university hospital

BACKGROUND: Crohn’s disease is a chronic inflammatory bowel disease. Treatment of outbreaks is based on corticoids, 5-ASA, nutritional support or anti-TNF alpha therapy (adalimumab, infliximab). The first-line background treatment consists in the use of azathioprine, 6-mercaptopurine and methotrexat...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Eur J Hosp Pharm
Autors principals: Cortes, B, Micol, M, Esteve, MA, Bertault-Peres, P, Roudot, M
Format: Artigo
Idioma:Inglês
Publicat: BMJ Group 2018
Matèries:
Section 4: Clinical pharmacy services
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7535607/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.245
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars